Oral Anticoagulants and Antiplatelet Agents in Atrial Fibrillation Patients with Concomitant Critical Limb Ischemia: A nationwide cohort study
ConclusionsDOAC was associated with a significantly lower risk of composite net-clinical-benefit outcome than either warfarin or APT in AF patients with concomitant CLI. Further prospective study is necessary to validate the findings in the future.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Canada Health | Cardiology | Chronic Kidney Disease | Coumadin | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Health Insurance | Heart | Heart Attack | Insurance | Ischemic Stroke | Stroke | Study | Taiwan Health | Urology & Nephrology | Warfarin